147 related articles for article (PubMed ID: 16263095)
1. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
[TBL] [Abstract][Full Text] [Related]
3. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin-1 (orexin A) levels are normal in Huntington's disease.
Baumann CR; Hersberger M; Bassetti CL
J Neurol; 2006 Sep; 253(9):1232-3. PubMed ID: 16598614
[No Abstract] [Full Text] [Related]
5. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
[TBL] [Abstract][Full Text] [Related]
6. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
7. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin-1 and secondary signs in Huntington's disease.
Roos RA; Aziz NA
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S387-90. PubMed ID: 18267269
[TBL] [Abstract][Full Text] [Related]
9. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
Rejdak K; Papuć E; Grieb P; Stelmasiak Z
Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
[TBL] [Abstract][Full Text] [Related]
10. CSF hypocretin levels are normal in Huntington's disease patients.
Gaus SE; Lin L; Mignot E
Sleep; 2005 Dec; 28(12):1607-8. PubMed ID: 16408421
[No Abstract] [Full Text] [Related]
11. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin (orexin) loss in Alzheimer's disease.
Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
[TBL] [Abstract][Full Text] [Related]
13. CSF hypocretin-1 levels are normal in multiple-system atrophy.
Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S
Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
[TBL] [Abstract][Full Text] [Related]
15. Hypocretin (orexin) loss in Parkinson's disease.
Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
[TBL] [Abstract][Full Text] [Related]
16. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
Björkqvist M; Petersén A; Nielsen J; Ecker D; Mulder H; Hayden MR; Landwehrmeyer B; Brundin P; Leavitt BR
Clin Genet; 2006 Jul; 70(1):78-9. PubMed ID: 16813610
[No Abstract] [Full Text] [Related]
18. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia.
Schwarcz R; Tamminga CA; Kurlan R; Shoulson I
Ann Neurol; 1988 Oct; 24(4):580-2. PubMed ID: 2977086
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
Maeda T; Nagata K; Kondo H; Kanbayashi T
Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
[No Abstract] [Full Text] [Related]
20. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome.
Kanbayashi T; Ishiguro H; Aizawa R; Saito Y; Ogawa Y; Abe M; Hirota K; Nishino S; Shimizu T
Psychiatry Clin Neurosci; 2002 Jun; 56(3):273-4. PubMed ID: 12047592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
